•
Dec 31, 2021

iRhythm Q4 2021 Earnings Report

iRhythm reported a revenue increase but decline in gross margin and adjusted EBITDA compared to Q4 2020.

Key Takeaways

iRhythm Technologies reported a 3.8% increase in revenue for the fourth quarter of 2021, reaching $81.8 million. However, the company experienced a decline in gross margin to 62.7% and an adjusted EBITDA of negative $17.3 million. The company's cash and short-term investments amounted to $239.1 million at the end of the year.

Q4 2021 revenue increased by 3.8% to $81.8 million compared to Q4 2020.

Gross margin decreased to 62.7%, an 11.3% decline compared to Q4 2020.

Adjusted EBITDA was negative $17.3 million, a $23.8 million decline compared to Q4 2020.

Cash and Short-Term Investments were $239.1 million at December 31, 2021, a $17.7 million decline from September 30, 2021.

Total Revenue
$81.8M
Previous year: $78.8M
+3.8%
EPS
-$1.1
Previous year: -$0.33
+233.3%
Gross Margin
62.7%
Previous year: 74%
-15.3%
Gross Profit
$51.3M
Previous year: $58.3M
-12.1%
Cash and Equivalents
$128M
Previous year: $88.6M
+43.9%
Total Assets
$463M
Previous year: $512M
-9.5%

iRhythm

iRhythm

Forward Guidance

iRhythm projects revenue for the full year 2022 to range from $400 million to $410 million, which represents 24% to 27% growth over prior year results. Gross margins for the full year 2022 are expected to range from 67% to 68% and adjusted operating expenses are expected to range between $375 and $385 million. Adjusted EBITDA for the full year 2022 is expected to range from negative $30 million to negative $40 million.